ARCHIVES

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

In Congress: Tamoxifen Results Well Communicated, Understood, NCI Says

May 1, 1998

NCI Advisory Group, Other Cancer Meetings

February 24, 1989

High-Dose Vitamin D With Docetaxel In Testing For Advanced Prostate Cancer

September 27, 2002

SWOG Phase III Trial To Test Treatment For Inoperable, Locally Advanced NSCLC

September 28, 2001

GAO Report Finds Hydrazine Sulfate Trials Were Accurate

September 29, 1995

In Brief: NIH Peer Review Reorganization Proposed By Advisory Panel; Comments Sought

September 3, 1999